Hospital-Acquired venous thromboembolism: A retrospective analysis of risk factor screening and prophylactic therapy

Hospital Pharmacy

Volumn 45, Issue 2, 2010, Pages 122-128

  Qazizada, Maryam ^a   McKaba, James ^a   Roe, Michael ^a  

^a St Vincent's Medical Center Jacksonville   (United States)

Author keywords

Deep vein thrombosis; Hospital acquired; Prophylactic therapy; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN;

AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ACQUIRED VENOUS THROMBOEMBOLISM; HOSPITAL READMISSION; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 77952964339     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4502-122     Document Type: Article

References (10)

1. Dowling NF, Beckman MG, Manco-Johnson M, et al. The U.S. Thrombosis and Hemostasis Centers pilot sites program. J Thromb Thrombolysis. 2007;23(1):1-7.
2. Beckman MG, Critchley SE, Hooper WC, Grant AM, Kulkarni R. CDC Division of Blood Disorders: public health research activities in venous thromboembolism. Arterioscler Thromb Vasc Biol. 2008;28(3):394-395.
3. Dorfman M, Chan SB, Maslowski C. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system. J Clin Pharm Ther. 2006;31(5):455-459.
4. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S-400S.
5. Nutescu EA. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. Am J Health Syst Pharm. 2007;64(11 Suppl 7):S5-13.
6. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3): 936-945.
7. Institute for Clinical Systems Improvement. Venous Thromboembolism Prophylaxis Guideline. 4th ed. 2007;1-52. http://www.icsi.org. Accessed June 16, 2008.
8. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest. 2000;118(6):1680-1684.
9. Hospital-Acquired Venous Thromboembolism (VTE) Incidence Calculator. Society of Hospital Medicine. http:// www.ihi.org/IHI/Topics/PatientSafety/ SafetyGeneral/Tools/ HospitalAcquiredVTEIncidenceCalculator.htm. Accessed June 16, 2008.
10. Lovenox [package insert]. Bridgewater, NJ: Sanofi-Aventis U.S. LLC; October 2007. http://products.sanofi-aventis.us/ lovenox/lovenox.html#2.2. Accessed June 16, 2008.